Vimarsana
Biggest News Aggregation in the World

Codon Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Codon Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Codon Capital Today - Breaking & Trending Today

Seismic Therapeutic Closes $121M Series B Financing - Vimarsana News

Seismic Therapeutic Closes $121M Series B Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

FogPharma's $178M Funding Leads Way as 7 Biotechs Raise Cash for Cancer Drugs - Vimarsana News

FogPharma's $178M Funding Leads Way as 7 Biotechs Raise Cash for Cancer Drugs

FogPharma is preclinical, but not for long. The biotech’s Series D financing round lays the groundwork to bring its lead program into the clinic in mid-2023, as well as support development of the rest of its pipeline of peptide drugs.

Roche shells out $250M to acquire Good Therapeutics and its preclinical oncology program - Vimarsana News

Roche shells out $250M to acquire Good Therapeutics and its preclinical oncology program

Roche announced it will acquire Good Therapeutics, a Seattle-based preclinical biotech, for $250 million. The deal makes Roche responsible for developing and commercializing Good's lead program, which seeks to make oncology drugs that target PD-1 proteins more effective, such as Keytruda or Opdivo.

Ansa Biotechnologies Closes Oversubscribed $68 Million Series A Financing to Power the Next Era of D - Vimarsana News

Ansa Biotechnologies Closes Oversubscribed $68 Million Series A Financing to Power the Next Era of D

Ansa’s next-generation enzymatic DNA synthesis technology will dramatically accelerate innovation across every industry enabled by synthetic DNA from biologic drugs to biomanufacturing, and DNA-based data storage.Funding will advance next-generation technology platform, expand R&D and manufacturing facilities, grow...

Ansa Biotechnologies Closes $68M Series A Financing - Vimarsana News

Ansa Biotechnologies Closes $68M Series A Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!